Immunology

Once inside a tumor, our immune cells become traitors

New research has found a subset of our immune cells (called regulatory T cells) that are highly abundant in the tumor microenvironment and are particularly good at suppressing the anticancer immune response. In two independent ...

Oncology & Cancer

Aging impacts therapeutic response of melanoma cells

Cancer risk increases with one's age as accumulated damage to our cells and chronic inflammation occur over time. Now, an international team of scientists led by The Wistar Institute have shown that aged tumor cells in melanoma ...

Oncology & Cancer

Scientists show how cancerous cells evade a potent targeted therapy

Imagine developing a drug designed to inhibit a protein that helps cancer cells proliferate and survive only to find that the drug does not perform very well in the clinic. This was the dilemma faced by scientists researching ...

page 16 from 40